Clinical Trials Logo

Clinical Trial Summary

This study aim to evaluate the efficacy of metoclopramide for gastric visualization in patients with active UGIB. This is a double-blinded, multicenter RCT. Patients with 'active' UGIB (hematemesis or presence of fresh blood in the nasogastric tube) were enrolled. The eligible patients were randomly assigned in a concealed 1:1 allocation to received either intravenous metoclopramide or placebo before endoscopy. The primary outcome was 'adequate visualization' by objective endoscopic visualized scores(EVS). Secondary outcomes included mean difference in total EVS and EVS at each location , duration of EGD, immediate hemostasis, need for a second look EGD, units of blood transfusion, length of hospital stay and 30-day rebleeding rate.


Clinical Trial Description

- This is double-blinded, multicenter RCT including six hospitals in Thailand. - The participated endoscopists had work experience for endoscopy more than three years. - All endoscopists at six participating sites attended the pre-study meeting for standardization of the protocol and scoring system. - The primary outcome was 'adequate visualization' by objective endoscopic visualized scores(EVS). ; To assess overall endoscopic visualization, we estimated the coverage of a blood clot on mucosa in four locations including 1) gastric fundus, 2) corpus, 3) antrum and 4) duodenal bulb, according to the reference endoscopic views in protocal. - All photos, including the reference endoscopic views, were taken and internally validated by another endoscopist who was blinded to the randomization allocation. - This study includes pre-specified subgroup analysis by location of bleeding including gastric subgroup analysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06167837
Study type Interventional
Source King Chulalongkorn Memorial Hospital
Contact Thanrada Vimonsuntirungsri, MD
Phone +66853356240
Email aa_choc@docchula.com
Status Recruiting
Phase Phase 4
Start date October 1, 2023
Completion date June 30, 2025

See also
  Status Clinical Trial Phase
Terminated NCT01448382 - Evaluation of PillCam With Blood-Sensing Feature: A Feasibility Study Phase 1
Recruiting NCT05746377 - Metoclopramide in Upper Gastrointestinal Bleed Phase 4
Recruiting NCT05582174 - PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers Phase 4
Not yet recruiting NCT06254352 - Clinical Risk Scores in Prediction Outcome of Acute UGIT Bleeding in Non Cirrhotic Patients
Recruiting NCT05415124 - Presence or Absence of Blood in the GI Lumen N/A
Recruiting NCT05474937 - Inhalation of Sevoflurane Versus Intravenous Midazolam,Ketamine,Propofol For Pediatrics Undergoing Upper GI Endoscopy N/A
Recruiting NCT05457062 - Analysis the Vocs in Upper GI Bleeding Patients
Recruiting NCT05876741 - Validation of Prognostic Accuracy of ABC ( Age, Blood Urea Nitrogen , Co-morbidities ) and Horibe Pre-endoscopy Scoring Systems in Patients With Upper Gastrointestinal Bleeding in Sohag University Hospital .
Recruiting NCT05763745 - Bedside Ultrasonic Assessment for Gastric Content in Patients With Upper GI Bleeding Undergoing Endoscopy: a Pilot Study N/A
Completed NCT03176407 - Detection of Upper Gastrointestinal (GI) Bleeding With a Novel Bleeding Sensor Capsule [DING] N/A